Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Article CommentaryBrain

On the Role of Screening for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease

J.P. Klein
American Journal of Neuroradiology August 2013, 34 (8) 1560-1561; DOI: https://doi.org/10.3174/ajnr.A3466
J.P. Klein
aDepartments of Neurology and Radiology Brigham and Women's Hospital and Harvard Medical School Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

Intracranial aneurysm (ICAN) formation is a well-known complication in patients with autosomal dominant polycystic kidney disease (ADPKD). In these patients, aneurysms are thought to form as a consequence of abnormal polycystin protein expression in vascular myocytes, which impairs the structural integrity of vessel walls.1⇓⇓–4 ICAN rupture with SAH is the most serious morbidity associated with ADPKD.

ICANs, both in ADPKD and the general population, are acquired abnormalities that are thought to form during a relatively short time. A defect in the elastic lamina of a vessel permits outward bulging, the extent of which is determined by the opposing forces of arterial blood pressure and residual elasticity of the vessel. A new aneurysm will either rupture or stabilize due to collagenous scarring. Aneurysms smaller than approximately 7 mm are less likely to rupture initially and may be less likely to expand with time. Because ICAN formation in ADPKD is associated with a defective vessel wall protein, the time course and dynamics of aneurysm stabilization and growth could potentially be altered. Most interesting, ICAN formation in ADPKD is not dependent on the presence of arterial hypertension,5,6 though ICAN rupture is.

The value of widespread radiographic screening for ICANs in asymptomatic patients with ADPKD is controversial, mainly because of the potential risk involved in pre-emptively treating incidentally detected aneurysms. Knowing which patients are more likely to have aneurysmal SAH could help stratify high-risk patients toward endovascular or surgical aneurysm repair and low-risk patients toward counseling and periodic imaging surveillance.7 One limitation of screening is that aneurysms that rupture around the time of their formation could be missed by infrequent imaging.

Regarding screening of asymptomatic patients, 3D time-of-flight MR angiography is the technique of choice because it avoids the risk assumed with contrast-based angiography, including iodinated contrast-induced nephropathy8 and gadolinium contrast-induced nephrogenic systemic fibrosis,9 as well as complications related to catheter-based angiography.10 For acutely symptomatic patients, urgent CT or catheter-based angiography should be performed.

Although the prevalence of ICANs in ADPKD increases with age, small studies have not demonstrated an increased rate of aneurysm growth and rupture compared with age-matched non-ADPKD populations.11,12 The risk of aneurysm rupture in ADPKD is linked to a family history of ICAN and prior SAH.5,6,13 In a retrospective study of 369 patients with ADPKD, the mean age of aneurysmal SAH in ADPKD was found to be slightly less than that in the general population (53 compared with 57 years of age).5 Additional risk factors for aneurysm rupture are extrapolated from the International Study of Unruptured Intracranial Aneurysms (ISUIA)14 and include aneurysm features such as size, shape, and location, as well as the presence of neurologic symptoms or signs. Now, patients with ADPKD with a family history of ICAN or prior SAH are routinely screened.

For patients with ADPKD without a family history of ICAN or prior SAH, the benefit of screening is less clear, and there are small clinical studies and meta-analyses advocating for6,15 and against11,12 routine screening. In the largest of these studies, which examined a cohort of 355 patients in China,6 the prevalence of ICAN increased with age, from 6.0% in the 30- to 39-year age group to 23.3% in the 60- to 69-year age group. On the basis of these findings, the authors favored screening all patients with ADPKD 30 years of age or older.

Niemczyk et al16 examined the prevalence of ICAN in ADPKD in a population of 83 adult patients in Poland. The data presented in this patient group were roughly concordant with those in other studies in terms of overall ICAN prevalence in ADPKD and increased ICAN prevalence with age. No risk factors were identified to predict ICAN rupture in younger patients. As in the study by Xu et al,6 the authors recommended screening all patients older than 45 years of age.

A recommendation to preferentially screen older patients with ADPKD should be balanced by safety analyses of potential endovascular or surgical interventions. Elevated morbidity and mortality rates in patients older than 50 years of age undergoing craniotomy and surgical clipping and older than 70 years of age undergoing endovascular coiling have been reported.17 Older patients with ADPKD commonly develop renal failure as well as arterial hypertension and may have even greater postoperative complications compared with younger patients with ADPKD or age-matched patients without ADPKD.

The economics of screening has been studied as well. A decision analysis of aneurysm screening versus nonscreening in ADPKD15 showed the greatest benefit in younger patients, in whom identification and treatment of an asymptomatic aneurysm increased life expectancy. As stated above, however, ICAN rupture in young patients is considerably rarer than in older patients. A risk analysis of treatment versus nontreatment based on ISUIA data18 did not favor clipping of unruptured aneurysms of <10 mm, though analyses of potential life-years saved in subgroups including ADPKD could not be calculated because the natural history and treatment risks in these subgroups are unknown.

The principles of a screening test, as originally described by the World Health Organization, include an understanding of the natural history of the disease in question as well as consensus on whom to treat.19 Whether the natural history of aneurysm formation, growth, and rupture risk in ADPKD parallels that of the general population remains unsettled. More data are needed from the ADPKD population to generate evidence-based guidelines for radiographic screening.

REFERENCES

  1. 1.↵
    1. Griffin MD,
    2. Torres VE,
    3. Grande JP,
    4. et al
    . Vascular expression of polycystin. J Am Soc Nephrol 1997;8:616–26
    Abstract
  2. 2.↵
    1. Torres VE,
    2. Cai Y,
    3. Chen X,
    4. et al
    . Vascular expression of polycystin-2. J Am Soc Nephrol 2001;12:1–9
    Abstract/FREE Full Text
  3. 3.↵
    1. Zhang B,
    2. Fugleholm K,
    3. Day LB,
    4. et al
    . Molecular pathogenesis of subarachnoid haemorrhage. Int J Biochem Cell Biol 2003;35:1341–60
    CrossRefPubMed
  4. 4.↵
    1. Brisman JL,
    2. Song JK,
    3. Newell DW
    . Cerebral aneurysms. N Engl J Med 2006;355:928–39
    CrossRefPubMed
  5. 5.↵
    1. Gieteling EW,
    2. Rinkel GJ
    . Characteristics of intracranial aneurysms and subarachnoid hemorrhage in patients with polycystic kidney disease. J Neurol 2003;250:418–23
    CrossRefPubMed
  6. 6.↵
    1. Xu HW,
    2. Yu SQ,
    3. Mei CL,
    4. et al
    . Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke 2011;42:204–06
    Abstract/FREE Full Text
  7. 7.↵
    1. Rinkel GJ
    . Intracranial aneurysm screening: indications and advice for practice. Lancet Neurol 2005;4:122–28
    CrossRefPubMed
  8. 8.↵
    1. Weisbord SD,
    2. Palevsky PM
    . Strategies for the prevention of contrast-induced acute kidney injury. Curr Opin Nephrol Hypertens 2010;19:539–49
    CrossRefPubMed
  9. 9.↵
    1. Mayr M,
    2. Burkhalter F,
    3. Bongartz G
    . Nephrogenic systemic fibrosis: clinical spectrum of disease. J Mag Reson Imaging 2009;30:1289–97
    CrossRefPubMed
  10. 10.↵
    1. Willinsky RA,
    2. Taylor SM,
    3. TerBrugge K,
    4. et al
    . Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology 2003;227:522–28
    CrossRefPubMed
  11. 11.↵
    1. Gibbs GF,
    2. Huston J 3rd.,
    3. Qian Q,
    4. et al
    . Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int 2004;65:1621–27
    CrossRefPubMed
  12. 12.↵
    1. Irazabal MV,
    2. Huston J 3rd.,
    3. Kubly V,
    4. et al
    . Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011;6:1274–85
    Abstract/FREE Full Text
  13. 13.↵
    1. Vlak MH,
    2. Algra A,
    3. Brandenburg R,
    4. et al
    . Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011;10:626–36
    CrossRefPubMed
  14. 14.↵
    1. Wiebers DO,
    2. Whisnant JP,
    3. Huston J 3rd.,
    4. et al.
    , for the International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103–10
    CrossRefPubMed
  15. 15.↵
    1. Butler WE,
    2. Barker FG 2nd.,
    3. Crowell RM
    . Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: a decision analysis. Neurosurgery 1996;38:506–16, discussion 515–16
    CrossRefPubMed
  16. 16.↵
    1. Niemczyk M,
    2. Gradzik M,
    3. Niemczyk S,
    4. et al
    . Intracranial aneurysms in autosomal dominant polycystic kidney disease. AJNR Am J Neuroradiol 2013;34:1556–59.
    Abstract/FREE Full Text
  17. 17.↵
    1. Wiebers DO,
    2. Piepgras DG,
    3. Meyer FB,
    4. et al
    . Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms. Mayo Clin Proc 2004;79:1572–83
    CrossRefPubMed
  18. 18.↵
    1. Mitchell P,
    2. Jakubowski J
    . Risk analysis of treatment of unruptured aneurysms. J Neurol Neurosurg Psychiatry 2000;68:577–80
    Abstract/FREE Full Text
  19. 19.↵
    1. Wilson JM,
    2. Jungner G
    . World Health Organization. Principles and Practice of Screening for Disease. Public Health Papers No. 34. Geneva, Switzerland; World Health Organization; 1968:1–163. http://whqlibdoc.who.int/php/WHO_PHP_34.pdf. Accessed January 12, 2013
  • © 2013 by American Journal of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 34 (8)
American Journal of Neuroradiology
Vol. 34, Issue 8
1 Aug 2013
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
On the Role of Screening for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
On the Role of Screening for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease
J.P. Klein
American Journal of Neuroradiology Aug 2013, 34 (8) 1560-1561; DOI: 10.3174/ajnr.A3466

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
On the Role of Screening for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease
J.P. Klein
American Journal of Neuroradiology Aug 2013, 34 (8) 1560-1561; DOI: 10.3174/ajnr.A3466
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Teaching NeuroImages: Huge carotid artery aneurysm in TSC2/PKD1 contiguous gene syndrome
  • Treatment of Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: Primum Non Nocere
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Fast Contrast-Enhanced 4D MRA and 4D Flow MRI Using Constrained Reconstruction (HYPRFlow): Potential Applications for Brain Arteriovenous Malformations
  • Multimodal CT Provides Improved Performance for Lacunar Infarct Detection
  • Optimal MRI Sequence for Identifying Occlusion Location in Acute Stroke: Which Value of Time-Resolved Contrast-Enhanced MRA?
Show more BRAIN

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2021 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2022 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire